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Abstract
Background: Tuberculosis (TB) remains a major global health problem and is the leading killer due to a single infectious
disease. Mobile health (mHealth)–based tools such as smartphone apps have been suggested as tools to support TB control efforts
(eg, identification, contact tracing, case management including patient support).
Objective: The purpose of this review was to identify and assess the functionalities of mobile apps focused on prevention and
treatment of TB.
Methods: We searched 3 online mobile app stores. Apps were included if they were focused on TB and were in English, Spanish,
or Portuguese. For each included app, 11 functionalities were assessed (eg, inform, instruct, record), and searches were conducted
to identify peer-review publications of rigorous testing of the available apps.
Results: A total of 1332 potentially relevant apps were identified, with 24 meeting our inclusion criteria. All of the apps were
free to download, but 7 required login and password and were developed for specific clinics, regional sites, or research studies.
Targeted users were mainly clinicians (n=17); few (n=4) apps were patient focused. Most apps (n=17) had 4 or fewer functions
out of 11 (range 1-6). The most common functionalities were inform and record (n=15). Although a number of apps were identified
with various functionalities to support TB efforts, some had issues such as incorrect spelling and grammar, inconsistent responses
to data entry, problems with crashing, or links to features that had no data. Of more concern, some apps provided potentially
harmful information to patients, such as links to natural remedies for TB and natural healers. One-third of the apps (8/24) had
not been updated for more than a year and may no longer be supported. Peer-reviewed publications were identified for only two
of the included apps. In the gray literature (not found in the app stores), three TB-related apps were identified as in progress,
being launched, or tested.
Conclusions: Apps identified for TB prevention and treatment had minimal functionality, primarily targeted frontline health
care workers, and focused on TB information (eg, general information, guidelines, and news) or data collection (eg, replace
paper-based notification or tracking). Few apps were developed for use by patients and none were developed to support TB patient
involvement and management in their care (eg, follow-up alerts/reminders, side effects monitoring) or improve interaction with
their health care providers, limiting the potential of these apps to facilitate patient-centered care. Our evaluation shows that more
refined work is needed to be done in the area of apps to support patients with active TB. Involving TB patients in treatment in
the design of these apps is recommended.
(JMIR mHealth uHealth 2016;4(2):e25)   doi:10.2196/mhealth.5022
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Tuberculosis (TB) remains a major global health problem and
is the leading killer due to a single infectious disease. The World
Health Organization (WHO) estimates that one-third of the
world population harbors latent TB infections, 14.1 million
people have active cases, 9 million are newly diagnosed per
year, and 1.5 million deaths are attributable to TB annually
[1-3]. This death toll equals 2% of global mortality, yet it is a
disease for which a cure has existed for 70 years. Given that
most deaths from TB are preventable, this death toll is
recognized by WHO as unacceptably high [1].
A number of factors contribute to the persistence of TB and its
high mortality rate. For example, factors that have been
identified as impacting TB medication adherence include length
of treatment course, complex regimens, medication side effects,
poor access to health care services, poor communication with
providers, lack of social support, negative perceptions, and
stigma and discrimination [4]. Directly observed therapy (DOT),
where a trained health care worker or treatment supporter
observes medication ingestion daily, is a WHO-recommended
strategy to provide patient support and assure drug adherence
for TB treatment. However, there are challenges to implementing
DOT in many settings [5]. For instance, DOT is labor-intensive,
transportation-dependent, and often inconvenient; therefore, in
some regions TB treatment is offered by self-administration
when attention from health care workers is unavailable, costly,
or difficult to access due to geographic distances [6,7]. No matter
how the treatment is given, heightening patients’ involvement
in their own care; improving communication between patients
and health care teams; and providing flexible patient-centered
care, education, and support to patients during treatment are
recommended to increase TB medication adherence [4,7].
There has been a rapid development of computers and
information technology in all aspects of life including health
care over the past 15 years [8]; one type of health care
information technology development is mobile health (mHealth).
Smartphone apps are reported to be ideal platforms for
improving health outcomes because of their popularity,
connectivity, and sophistication [9]. Increasingly, apps can
support added functionalities beyond, for example, text
messaging and have the potential for real-time data collection,
graphic feedback, interactivity, and links to social functionalities.
Apps are being developed as tools to support multiple aspects
of health care, including prevention, diagnosis, data collection,
treatment adherence monitoring, and disease surveillance. Apps
have the potential to support TB prevention and treatment efforts
by supporting health care providers in diagnosing TB,
monitoring patient progress, and providing support to patients
to successfully complete treatment [6].
In the past few years, the number of health-related apps available
to consumers has more than doubled for the two leading
platforms, iOS and Android [10]. A study published in 2015 by
the IMS Institute for Health care Informatics identified more
than 165,000 health-related apps [11] compared to about 40,000
in its 2013 report [12]. While there is a large literature base on
human-computer interaction in many areas [13-15], the methods
for review and assessment of health-related apps are evolving.
Prior reviews report systematic methods for conducting searches
in the literature and app stores to describe the breadth of apps
available [16,17], while others have added detailed identification
of characteristics and primary purpose of apps [18]. Shen et al
[19] and Bender et al [20] developed their own app characteristic
coding schemes to meet the needs of their review focus that
included functionality criteria assessment such as media type,
user interface, and inclusion of tools to identify disease before
symptom or signs. Previously, we have used the criteria
proposed by the Institute for Healthcare Informatics specifically
to assess app functionalities [12]. Reviews exist for identifying
apps to support treatment of chronic diseases such as diabetes
and [17] chronic pain [16,18] as well as for the prevention,
detection, and management of cancer and [20] depression [19].
We have conducted prior reviews assessing the prevention of
infectious diseases such as health care-associated infection
prevention [21] and HIV [22]. However, no studies have
assessed available apps to support TB prevention or treatment.
To fill this gap, we conducted this systematic review to identify
the TB prevention and/or treatment support-related apps
available, report on their characteristics, and assess their
functionalities. Our objectives were to (1) detect the number of
TB-related apps available in the main app stores, (2) describe
their characteristics, (3) evaluate their range of functionalities,
(4) identify any rigorous testing of the available apps, and (5)




Methods to identify, evaluate, and report findings for this study
were guided by the Quality and Risk of Bias Checklist for
Studies that Review Smartphone Applications [23] and the app
functionality categories described in the Institute for Healthcare
Informatics report [12]. The checklist comprises 8 criteria for
evaluating and reporting the quality of smartphone health-related
apps (eg, data collection time frame, clearly described app search
strategy, concise description of the app appraisal methods). This
checklist helped guide the search strategy and data characteristic
extraction form development and ensure completeness of
reporting of the results. The adapted app appraisal method,
based on the app functionality categories from the Institute for
Healthcare Informatics report, is described and defined below
(see Table 1) [12].
Search Strategy and App Selection
We conducted searches in 3 mobile app stores in the United
States during June 2015: iTunes App Store, Google Play Store,
and Amazon Appstore. We used the search terms tuberculosis,
TB, phthisis, and tuberculosein each of the app stores. Apps
were included if they focused on TB control efforts (eg, patient
support, health care provider management, TB awareness) and
excluded if they were not dedicated to TB efforts (eg, focused
on other infectious diseases were games or unrelated) and not
in English, Spanish, or Portuguese.
Two team members, SI and LO, independently reviewed titles,
full marketing descriptions, and screenshots of the potential
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apps for relevance and inclusion and discussed discrepancies
until consensus was reached. All apps not meeting inclusion
criteria were excluded. The list was then reviewed for duplicate
apps identified from multiple searches and terms and “lite” or
demo versions of apps to produce the final list of unique apps
(see Figure 1 flowchart).
Figure 1. Flowchart.
Data Abstraction and App Functional Appraisal
Each eligible app was downloaded for functional appraisal.
Emails were sent to listed company contacts for each of the
apps requiring login and password to enter the full app content.
We provided the purpose of this study and requested a test code,
password, or further information about the app’s functionalities.
A data abstraction form (available upon request) was developed
based on the app functionality criteria from the Institute for
Healthcare Informatics report [12] and a prior app evaluation
data abstraction process [21]. Each app was characterized for
store availability (eg, Apple, Amazon), country developed,
target end-users, cost to download, number of downloads, rating
and number of reviewers contributing to the rating, date of last
update, primary purpose, and any specific issues or features of
apps (eg, audio function to read text, language options). The
app functionalities were appraised based on the 7 functionality
criteria and 4 functional subcategories (Table 1). Each app was
assessed for having or not having each of the 11 functionalities
and given a functionality score (0-11).
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Table 1. App evaluation criteria.
DefinitionFunctionality
Provide information; can be in a variety of formats such as text, photo, or videoInform
Provide instructions to the user (eg, specific steps to take for TB test or diagnosis)Instruct
Capture user-entered data and record functional subcategoriesRecord
• Collect: enter and store health data on individual phone
• Share: transmit health data (eg, upload, transfer, email)
• Evaluate: evaluate the entered data
• Intervene: send alerts based on the data collected or propose behavioral interventions or changes (eg, alert to treatment
provider regarding treatment adherence, alert user for TB dosage due)
Display user-entered data graphically and provide an output (eg, report, medication log, contact screening results, search results)Display
Provide guidance based on user-entered information (eg, patient TB risk factor screening and recommendations for testing,
medication dosage based on entered data - weight/age). Having the function to enter search terms to obtain information or diag-
nostic criteria was not considered a guide functionality
Guide
Provide reminders to the user (eg, medication, follow-up appointments)Remind/alert
Facilitate communication between providers, patients, consumers, caregivers, and medication administrators or provide links to




Search queries yielded 1332 potentially relevant apps, of which
24 were included in our review. Most of the apps were excluded
because they were not TB-related. See Figure 1 flowchart for
selection process and categories for exclusion. Multimedia
Appendix 1 provides the full list of the included apps and their
characteristics. All of the apps were free to download; however
7 were developed for specific settings (eg, countries and/or
clinical or research sites) and had restricted access requiring a
login and password. The target end-users for most apps (n=17)
were health care providers (eg, frontline health care worker,
clinician, or lab technician) while a few (n=4) were
patient-focused or could be used by patients and providers (n=3).
A total of 13 apps were rated by 2 to 40 reviewers, and the mean
rating was 4.4 (range 3.7-5, SD 0.5) on a scale of 1-5. Of the
18 apps with a reported range of downloads, 11 had been
downloaded less than 500 times.
Functionality
Multimedia Appendix 2 provides the included app functionalities
and scores based on the 7 functionality criteria and 4 functional
subcategories adapted from the Institute for Healthcare
Informatics report. Most apps (n=17) had 4 or fewer functions
out of 11 (range 1-6). The most common functionalities were
inform and record (n=15). There were 6 apps with the functions
to display, guide, remind/alert, or communicate. For those with
the function to inform, the majority focused on providing
information on TB diagnosis, treatment (eg, medication,
regimen, and age considerations), and transmission. The 3 apps
that had an alert/reminder function (eCompliance, eDetection,
and MDR-TB MDR Clinic) were for health care workers to
display reports of expected appointments or pending
questionnaires needed during home visits. The function to
communicate was restricted to access to a social media link
such as Facebook page (Tuberculosis News, TB Proof) (Figure
2) or an email contact to report app problems (Explain TB,
SNTC).
The Explain TB app provided information in audio form and
in multiple languages (Figure 3). One app did not function once
downloaded (GuiaTB) and another crashed when opening a
form within the app (eMocha). Seven of the apps require logins
and passwords to access full functionality (eCompliance [Kenya,
Jubilant Bhartia], eDetection, MDR-TB MDR Clinic
Application, MDR-TB PHC Application, Global Fund TB,
MINE TB, and TB REACH 4–Kotri).
Of the apps with the functionality to record, most collected
(n=11) and shared data (n=10) (eg, sync to database or email
results). Only 3 apps, CAD4TB, FIND TB, and TB Mobile, had
the subfunction to evaluate (eg, provided feedback based on the
data entered).
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Figure 2. Tuberculosis News, TB Proof.
Figure 3. Explain TB.
Issues With Included Apps
Although a number of apps were identified as having various
functionalities to support TB efforts, some had issues such as
incorrect spelling and grammar, inconsistent responses to data
entry, problems with crashing, or links to features that had no
data.
For example, the Tuberculosis Symptoms Guide app (Figure
4) provides a TB syndrome screening form with 4 questions.
The questions are as follows and are written verbatim from the
app: Is the patient age 12 years? Is the patient HIV infected?
Has the patient is in close contact with TB patients in home or
at work? Does the patient has any symptoms? The recommended
action provided after completing the screening questions is the
same for all variations of responses (e.g., selecting “no” or “yes”
to all questions). The response provided after answering the
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questions is: “The patient has systomps of TB he/she must be
tested as soon as possible by a health care professional to
determine the TB. If he/she is detected TB then the family
members should also be checked for TB.” In addition, this app
has nonfunctioning Contact Us and FAQ tabs, lists only the
names of 5 TB drugs without further information, and has many
words misspelled (eg, nigtht sweats, systomps of TB).
The eMOCHA TB Detect app has tabs for TB symptom
screening, education (TB lectures, courses, and library), and a
disclaimer. As of July 2015, there are video lectures on
prevention and risks for acquiring TB and two tables in the
library; however, there were no courses available. When
selecting the TB symptom screening form, the app crashes and
closes. This app was last updated in 2013 and may no longer
be supported. Similarly, GuiaTB could be downloaded but
crashed upon opening; it appears to no longer function or be
supported.
Of more concern were the apps that provided potentially harmful
information. Tuberculosis (Amazon and Google) lists home
remedy options or links to natural healers (Figures 5 and 6). For
example, Tuberculosis (Google) provides links to information
on medicinal herbs for treating TB and states “It seems like a
cure all because it kills and neutralizes poisons;” these herbs
are not consistent with evidence-based guidelines [24]. In
addition, this app has many language options under settings but
only the tabs and functions labels change language and not the
content presented.
Figure 4. Tuberculosis Symptoms Guide.
Figure 5. Tuberculosis (Amazon). Home remedies.
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Figure 6. Tuberculosis (Google).
Formal Research Studies on TB-Related Apps
Peer-reviewed publications were identified for only two of the
included apps. A formal research study was conducted to
evaluate the app CAD4TB. Researchers conducted a cohort
study to assess the app’s sensitivity and specificity and found
it helped accurately distinguish between the chest radiographs
of culture-positive TB cases and controls [25]. Two publications
described the development, features, and update of the TB
Mobile app [26,27]. The researchers curated and prioritized
data on molecules available in the Collaborative Drug Discovery
database. App users can input molecular structures and search
for potential targets to retrieve compounds known to be active.
The authors state that the TB Mobile app has the potential to
assist researchers in identifying targets for the development of
antituberculosis drugs and purport that this mobile
“cheminformatics” app could lower the barrier to drug discovery
and promote collaboration among drug developers.
Another peer-reviewed publication reported on the design and
piloting of a TB-related app not found in the app stores
(Mobilize) [28]. Mobilize was developed to support health care
workers in recording and tracking patients with
multidrug-resistant TB. Last, the Centers for Disease Control
and Prevention posted information on its webpage about the
CDC LTBI app and its features [29] but there was no formal
research study reported.
TB-Related Apps in the Gray Literature
Three TB-related apps were identified in the gray literature (not
found in the app stores) as in progress, being launched, or in
testing (DOTsync, Nikshay, and an unnamed app to assist in
contact tracing). DOTsync is described as replacing paper-based
systems and providing community workers with a tool to
document DOT, monitor infection control and drug
complications, track nutritional support, and conduct TB contact
tracing [30]. The DOTsync app was developed by FHI 360’s
Control and Prevention of Tuberculosis project and the Myanmar
Medical Association. Nikshay, launched by the government of
India, aims to decrease the lengthy process of notifications,
provide clinicians with a simpler case notification tool, and link
the data to the Central Tuberculosis Division of the Ministry of
Health and Family Welfare [31]. The aim of Nikshay is to
increase enrollment in the national TB program, make the
process easier for health care providers, and improve private
sector reporting. The rollout started in March 2014 with email
notification of the app being sent to general practitioners in
Mumbai. The last app was unnamed but referred to in a poster
abstract as an app developed to digitalize and automate contact
tracing documentation in Botswana [32]. Preliminary results
indicated that the app eliminated the need for manual data entry
into the contact tracing database, required all form fields to be
completed electronically prior to submission, automatically
generated weekly and cumulative reports, and accurately
captured the geographic coordinates of case homes. However,
a final report was not identified in the literature.
Discussion
Principal Findings
The number of mHealth tools such as smartphone health-related
apps has increased exponentially. As access to mobile phones,
particularly smartphones and feature phones with the capacity
to include mobile apps, continues to increase globally, the
opportunity to harness their potential as a health-promoting tool
grows as well. In conducting this research, we identified and
evaluated functionalities of apps aimed at supporting TB
prevention and treatment that were available in the leading
mobile app stores. In addition, we identified apps reported in
formal research studies and in the gray literature. Our review
focuses on a specific, challenging disease and explores how
apps available in the largest app stores might support TB
prevention and treatment.
Almost all of the identified apps targeted health care providers
as end-users, and the majority provided access to a broad
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spectrum of TB information or tools aimed to support these
workers in monitoring, detecting, and documenting visits.
Similarly, the apps identified in the gray literature were reported
to support frontline health care workers in documentation of
cases, contact tracing, or management of patients. One app was
designed to support those aiming to identify and develop new
TB treatment development options.
There was a clear lack of apps specifically designed to provide
treatment support and care management for patients or promote
their involvement in their treatment. The apps targeting patients
as end-users provided information on TB disease, symptoms,
diagnostics, treatment, and transmission. None of the apps were
developed for patients to help them with their treatment regimen
(eg, reminders/alerts for follow-ups). Opportunities have been
recognized for mHealth and mobile apps to be developed for
chronic and infectious diseases such as HIV, but apps for TB
control have not been developed to the same extent [6].
Few TB-related apps were found to have undergone formal
research evaluation. The app Mobilize (identified in the literature
but not available in any of the app stores) was reported as
feasible and effective at decreasing adverse events and
improving communication; however, the authors report that app
uptake was poor, and health care workers cited forgetfulness
and a belief that patients should take more responsibility for
their own care as reasons for not consistently using the app [28].
The authors recommend exploring the motivations of health
care workers and technological enhancements prior to scaling
up mHealth tools.
A few apps presented information that misinformed patients
about appropriate TB treatment options. Misinformation in
health care apps has been problematic in other areas (eg, Acne
App claimed that its mobile app could cure acne by emitting
colored light from a cell phone). The US Federal Trade
Commission sued the marketer of this app claiming it was unfair
and deceptive and provided information potentially harmful to
patients. However, with more than 100,000 health-related apps
estimated to be in production, it is difficult to regulate and
oversee app content. There is a real concern that app users can
be misinformed-especially given the lack of regulations. The
US Food and Drug Administration in 2013 indicated that it will
be overseeing apps that capture and transfer patient data [33,34];
however, the rest of the app content is left up to the developers.
Currently, there are no specific regulations to assure
reliability/validity of information.
Another issue was the lack of current support and/or
functionality for some apps despite availability from an app
store. In a prior review of HIV apps, we also found apps that
no longer functioned. On the positive side, the apps we assessed
requiring log-ins and passwords use OpenMRS [35] (an open
source enterprise electronic medical record system) are
supporting interoperability across programs and likely
addressing issues of data security and privacy as recommended
in the Principles for Digital Development [36].
Implications
Existing mHealth tools can be improved and reused before new
development is considered [36], but findings from this review
suggest the need for development of apps for TB treatment for
patients with the active disease. Apps that improve interaction
with health care providers and support TB patient management
and involvement in care appear to be lacking. Developing apps
targeted at patients as end-users and involving TB patients in
the design of these apps is recommended.
Although the checklist of 8 criteria for evaluating the quality
and risk of bias for app evaluations is a helpful guide, its authors
do not provide the criteria development process and indicate
that the criteria were based on “simple facts and research
transparency” [23]. In addition to the 8 criteria, we recommend
specifying the last date updated because it is important to
identify if the app continues to be managed/supported and is
consistent with the most current clinical recommendations and
guidelines. We also recommend including the country or setting
for which the app was developed. The app characteristic
evaluations have not been standardized. After we conducted
our review, Stoyanov et al [37] published a mobile health app
rating scale to classify and rate the quality of apps using 5
measures. In addition to app functionalities, the authors
recommend review of patient engagement, aesthetics, and
subjective quality. Our review assessed the range of downloads
and user review ratings which may help inform the use and
potential uptake. In addition, conducting searches outside of
the app stores, such as in the gray literature, is helpful to identify
apps under development or in production.
Limitations
This review has a number of limitations. First, app stores have
limited advanced searching capabilities; therefore, we may have
missed potentially eligible apps. However, we conducted broad
searches with multiple terms to capture any apps meeting our
broad inclusion criteria. In addition, based on our gray literature
search findings, there appear to be other TB-related apps being
trialed that have not been released to the public or in the app
stores. We describe the apps in development that we identified,
but there may be others that were missed.
Second, we attempted to capture apps in 3 languages (English,
Spanish, and Portuguese). However, only one app was identified
in Portuguese and none were in Spanish. It is possible that,
depending on the country from which the searches were
conducted, the apps available at the app stores may vary and
apps in these languages were not made available outside of their
region, but it would be surprising to limit access to apps
available in Spanish within the United States. Also there were
apps in other languages that we had to exclude because we were
unable to assess them.
Third, not all app stores provide the same data, and not all apps
could be fully accessed. For example, the Amazon Appstore
does not provide information on range of downloads or date of
last update (only release dates are provided) and none of the
apps had been rated or reviewed at time of this review. To
overcome the limitation on accessing apps, we sent email
inquiries to all of the app contacts that required login and
password but did not receive a response from any of them.
Therefore, for 7 apps we conducted the functionality assessments
using the online screenshot images and marketing descriptions.
The online screenshots contained from 2 to 7 screenshots for
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each app providing, in most cases, sufficient views to assess
each functionality.
Last, although it was not the aim of our review, it is possible
that there are apps for medication support that could provide
medication management for patients on any treatment regimen,
including TB. However, it is likely that they would not provide
other TB-specific support such as information on infectivity,
testing for close contacts, and common side effects of TB
medications.
Comparison With Prior Work
Prior reviews of apps were not TB-specific, did not include a
functionality score, or did not search for apps in the gray
literature [20,21,38-42]. An evaluation of HIV apps included
an audit of formative patient-identified app function needs and
preferences. Shen et al [19] evaluated apps based on their store
description to provide an overall description of depression apps.
De la Vega and Miro [16] could find no articles published on
apps they identified in app stores for pain management but did
find articles published on apps not available in app stores. They
identified a gap between the scientific and commercial faces of
mHealth.
Conclusions
In our review, apps identified for TB efforts had minimal
functionality, primarily targeted frontline health care workers,
and focused on TB information (eg, general information,
guidelines, and news) or data collection (eg, replace paper-based
notification or tracking). Few apps were developed for use by
patients and none were developed to support TB patient
involvement and management in their care (eg, follow-up
alerts/reminders, side effects monitoring) or to improve
interaction with their health care providers, limiting the potential
of these apps to facilitate patient-centered care. Given the
complex challenges faced by patients with TB, there is a need
for further app development targeting their needs. Our evaluation
shows that more refined work is needed in this area. Involving
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